Cause of death revealed after college football star's tragic death at 21
UNLV football player Ben Christman died from cardiac arrhythmia, an irregular heartbeat and cardiomyopathy - a disease that makes it harder for the heart to pump blood around the body.
That is according to the coroner in Nevada who examined the body of the 21-year-old, who was found dead in his apartment back in February.
At the time, police documents - obtained by TMZ - revealed that Christman experienced chest pains during practice the day before his death.
Christman reportedly underwent an EKG - a test to check the heartbeat - on February 10 after complaining of chest pains, with a cardio doctor subsequently reviewing the tests but not finding anything alarming.
Following that practice, Christman reportedly returned home at around 3pm and went straight into his room after briefly greeting his roommate.
The next day, according to police documents, Christman was found by a teammate lying on his back, foaming at the mouth and with purple fingers.
A police officer reportedly arrived at the scene on the morning of February 11 - following a 911 call - and determined that Christman had been deceased for 'a few hours' due to the color of his right arm. The person who placed the 911 call and another teammate were administering CPR when the officer arrived.
Christman had missed practice that morning, leading his teammates to check on him. The roommate told cops that he had not seen Christman since he went into his room following the previous day's practice.
The school released an emotional statement following Christman's death. 'Our team's heart is broken to hear of Ben's passing,' new Rebels head coach Dan Mullen said.
'Since the day Ben set foot on our campus a month ago, he made the Rebels a better program. Ben was an easy choice for our Leadership Committee as he had earned the immediate respect, admiration and friendship of all his teammates.'
'Our prayers go out to his family and all who knew him. Ben made the world a better place and he will be missed.'
Christman had transferred to UNLV earlier this year after two seasons at Kentucky. Before that, he was a four-star recruit out of high school and played for two years at Ohio State.
The 6-foot-6, 325-pound Christman was entering his final season of college eligibility.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Focus: US pharma bets big on China to snap up potential blockbuster drugs
June 16 (Reuters) - U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments. Through June, U.S. drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters. That increased pace is expected to continue as U.S. drugmakers look to rebuild pipelines of future products to replace $200 billion worth of medicines that will lose patent protection by the end of the decade, analysts, investors, a banker and a drug company executive told Reuters. "They are finding very high-quality assets coming out of China and at prices that are much more affordable relative to perhaps the equivalent type of product that they might find in the United States," said Mizuho analyst Graig Suvannavejh. The total cost of licensing agreements, including low upfront payments and subsequent larger payouts, averaged $84.8 billion in the U.S., compared with $31.3 billion in China over the past five years, according to GlobalData. A licensing agreement grants a company the rights to develop, manufacture, and commercialize another company's pharmaceutical products or technologies in exchange for future target-based, or "milestone", payments while mitigating development risks. China's share of global drug development is now nearly 30%, while the U.S. share of the world's research and development has slipped 1% to about 48%, according to pharmaceutical data provider Citeline's report in March. Chinese companies have licensed experimental drugs to U.S. drugmakers that could be used for obesity, heart disease and cancer, reflecting abundant Chinese government investment in pharmaceutical and biotech research and development. While small molecules, like oral drugs, have been the most commonly licensed, there has been a notable shift toward novel treatments such as targeted cancer therapies and first-in-class medicines, Jefferies analysts said in a note in May. "Chinese biotechs are moving up the value chain by the day. They are... challenging their Western peers," said Macquarie Capital analyst Tony Ren. The growth is happening even as the U.S. and China have wrangled over tariffs and U.S. President Donald Trump pushes a made in America agenda. That has cut into traditional mergers and acquisitions, which are down 20%, with only 50 such transactions so far this year, according to data from database. Roughly a third of the assets that large pharmaceutical companies licensed in 2024 were from China, said Brian Gleason, head of biotech investment banking at Raymond James, who estimated such licensing deals would increase to between 40% and 50%. "I think it's only accelerating," Gleason said. The Trump administration is currently doing a national security investigation as it weighs if it will impose tariffs on the pharmaceutical sector. But one healthcare analyst said licensing deals should continue because the yet to be marketed products are not impacted by tariffs. "The law that gives the president the right to impose tariffs applies to goods. It explicitly excludes intellectual property," said Tim Opler, managing director in Stifel's global healthcare group. In May, Pfizer (PFE.N), opens new tab spent $1.25 billion upfront for the right to license an experimental cancer drug from China's 3SBio ( opens new tab. That is the largest such deal this year and could be worth up to $6 billion in payments to 3SBio if the drug is successful. Regeneron Pharmaceuticals (REGN.O), opens new tab in June paid $80 million upfront in a potential $2 billion deal for an experimental obesity drug from China's Hansoh Pharmaceuticals ( opens new tab. By licensing a drug in development, U.S. and European drugmakers get very quick access to a molecule which would take them longer and cost more to discover or design themselves, analysts say. U.S.-based drug developer Nuvation Bio (NUVB.N), opens new tab bought AnHeart Therapeutics in 2024, gaining access to the China-based company's experimental cancer drug taletrectinib, which received U.S. approval last week. "We consider our presence in China not only a great avenue for R&D, but we also view it as an inside track on obtaining further assets to grow our company further and find new and better therapies to offer patients," Nuvation CEO David Hung told Reuters. What makes China attractive, said EY analyst Arda Ural, "a fraction of the cost and then multiples of time." Analysts have pointed to large drugmakers strategically securing rights to drugs at lower cost and running efficient early-stage trials in China to obtain important data, paving the way for global trials and potential earlier market entry. "It's a little bit of a wakeup call to our industry," said Chen Yu, Managing Partner at U.S.-based healthcare investment firm TCGX.
The Guardian
an hour ago
- The Guardian
Terrible things happen in life - but it is possible to recover from them
We can try as hard as we like to build a better life for ourselves and our loved ones, but the truth is that sometimes things happen that are very difficult to recover from. Terrible, traumatising, crushingly painful things. If you are someone who has experienced abuse; lost a loved one too young; lost a baby or a child; wanted a child and not been able to have one for whatever reason; suffered irreparable injury to your body and your mind; or survived any tragedy that has left you drowning in despair, a better life may feel absolutely and irredeemably out of your grasp. I understand this. I have seen it many times in my consulting room, and although I have been very fortunate in my life, I have also known that feeling of certainty that there are some traumas that you just cannot recover from. When you're in the middle of it, or stuck in its aftermath, that is all there is. But I have learned, as a patient in therapy and as a therapist, that it can become possible for pain and trauma to be attended to, put into words and understood. And this can include the most overwhelming, unimaginable, earth-shattering losses. This is easier described than done. We go to all sorts of lengths – often unconsciously – to hide from what hurts, to obscure the true meaning behind our pain. Sometimes, we believe we are in pain, but actually we aren't – we are avoiding it, pushing it away, turning our backs to it. Like hearing someone crying, and quietly slipping out of the house and closing the door. Take anxiety. A person might seek therapy because they want help for life-sapping anxiety symptoms – from the pounding in their chest to the racing thoughts in their head and the whole mind-and-body clench that means they struggle to get out of bed. They are miserable. But what I discovered is that it can be easier, in some ways, to feel miserable about anxiety symptoms than to feel the emotions we are running away from. These physical and psychological symptoms can emerge as a more acceptable diversion from the deeper emotional anguish that we cannot bear to face. It might, unconsciously, seem preferable to be in anxiety than to be in pain. But if we are to stand a chance of being able to understand the meaning in our suffering, we need to turn towards the feelings, the memories and the losses that anxiety leads us away from. If you're paralysed by anxiety, you aren't living your life. But if you are in pain and you know why, perhaps because you are longing for something you cannot have – love, security, a mother, a child – and you give voice to that pain, even if only within your own mind, if you put it into words and listen to it, attend to it, then you can understand the meaning of your suffering and come alive. There is consolation in that, and it is very different from leaving yourself to cry behind a closed door. This is different from what people call 'dwelling' on or in something, which implies a kind of wallowing, like worrying a wound. Feeling your pain is what makes movement possible, while turning away from it ensures you will stay stuck in it. Perhaps this is what the psychoanalyst Wilfred Bion was exploring when he wrote that good therapy should 'increase the patient's capacity for suffering'. There's just one more thing I wanted to say about this. When something terrible happens to you, there is often an assumption – spoken or unspoken – that it was your fault. It is of course possible that had you made different decisions, had it been possible for you to act differently, this thing might or might not have happened – and that can be very painful, but crucial, to recognise. It might also be the case that nothing could have prevented this thing from happening; that it was quite simply out of your hands, which is a truly terrifying thing to contemplate. It might even feel better to hold on to your misplaced guilt, because this belief that it was your fault protects you from the reality that terrible things can happen and there is absolutely nothing we can do about it. The famous scene in Good Will Hunting when Robin Williams tells Matt Damon: 'It's not your fault' is so powerful because Damon's character thinks he already knew that, but we can see when he breaks down that he didn't actually believe it. What doesn't ring true about that scene for me is that he eventually believes it because Williams tells him – in my experience, it doesn't work like that. This is something we cannot be told by someone else; we have to find this truth inside ourselves. It is devastating to face this reality. But counterintuitive though it may be, a better life can grow out of the anguish of recognising that we are not in control. Because although we cannot control what happens to us, when we can allow the experience of our true suffering, our pain and our grief, we can find understanding and a capacity for compassion, for ourselves and others too. Moya Sarner is an NHS psychotherapist and the author of When I Grow Up – Conversations With Adults in Search of Adulthood Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here.
The Guardian
an hour ago
- The Guardian
‘Extremely disturbing and unethical': new rules allow VA doctors to refuse to treat Democrats, unmarried veterans
Doctors at Department of Veterans Affairs (VA) hospitals nationwide could refuse to treat unmarried veterans and Democrats under new hospital guidelines imposed following an executive order by Donald Trump. The new rules, obtained by the Guardian, also apply to psychologists, dentists and a host of other occupations. They have already gone into effect in at least some VA medical centers. Medical staff are still required to treat veterans regardless of race, color, religion and sex, and all veterans remain entitled to treatment. But individual workers are now free to decline to care for patients based on personal characteristics not explicitly prohibited by federal law. Language requiring healthcare professionals to care for veterans regardless of their politics and marital status has been explicitly eliminated. Doctors and other medical staff can also be barred from working at VA hospitals based on their marital status, political party affiliation or union activity, documents reviewed by the Guardian show. The changes also affect chiropractors, certified nurse practitioners, optometrists, podiatrists, licensed clinical social workers and speech therapists. In making the changes, VA officials cite the president's 30 January executive order titled 'Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government'. The primary purpose of the executive order was to strip most government protections from transgender people. The VA has since ceased providing most gender-affirming care and forbidden a long list of words, including 'gender affirming' and 'transgender', from clinical settings. Medical experts said the implications of rule changes uncovered by the Guardian could be far-reaching. They 'seem to open the door to discrimination on the basis of anything that is not legally protected', said Dr Kenneth Kizer, the VA's top healthcare official during the Clinton administration. He said the changes open up the possibility that doctors could refuse to treat veterans based on their 'reason for seeking care – including allegations of rape and sexual assault – current or past political party affiliation or political activity, and personal behavior such as alcohol or marijuana use'. The Department of Veterans Affairs is the nation's largest integrated hospital system, with more than 170 hospitals and more than 1,000 clinics. It employs 26,000 doctors and serves 9 million patients annually. In an emailed response to questions, the VA press secretary, Peter Kasperowicz, did not dispute that the new rules allowed doctors to refuse to treat veteran patients based on their beliefs or that physicians could be dismissed based on their marital status or political affiliation, but said 'all eligible veterans will always be welcome at VA and will always receive the benefits and services they've earned under the law'. He said the rule changes were nothing more than 'a formality', but confirmed that they were made to comply with Trump's executive order. Kasperowicz also said the revisions were necessary to 'ensure VA policy comports with federal law'. He did not say which federal law or laws required these changes. Until the recent changes, VA hospitals' bylaws said that medical staff could not discriminate against patients 'on the basis of race, age, color, sex, religion, national origin, politics, marital status or disability in any employment matter'. Now, several of those items – including 'national origin,' 'politics' and 'marital status' – have been removed from that list. Similarly, the bylaw on 'decisions regarding medical staff membership' no longer forbids VA hospitals from discriminating against candidates for staff positions based on national origin, sexual orientation, marital status, membership in a labor organization or 'lawful political party affiliation'. Dr Arthur Caplan, founding head of the division of medical ethics at New York University's Grossman School of Medicine, called the new rules 'extremely disturbing and unethical'. Sign up to This Week in Trumpland A deep dive into the policies, controversies and oddities surrounding the Trump administration after newsletter promotion 'It seems on its face an effort to exert political control over the VA medical staff,' he said. 'What we typically tell people in healthcare is: 'You keep your politics at home and take care of your patients.'' Caplan said the rules opened the door to doctors questioning patients about whether they attended a Trump rally or declining to provide healthcare to a veteran because they wore a button critical of JD Vance or voiced support for gay rights. 'Those views aren't relevant to caring for patients. So why would we put anyone at risk of losing care that way?' Caplan said. During the 2024 presidential campaign and throughout the early months of his second term, Trump repeatedly made threats against a host of people whom he saw as his political antagonists, including senators, judges and then president Joe Biden. He called journalists and Democrats 'the enemy within'. In interviews, veterans said the impact of the new policy would probably fall hardest on female veterans, LGBTQ+ veterans and those who live in rural areas where there are fewer doctors overall. 'I'm lucky. I have my choice of three clinics,' said Tia Christopher, a navy veteran who reported being raped in service in 2000. Based in Pittsburgh, Pennsylvania, Christopher advocates on behalf of military sexual trauma survivors throughout the country. Under the new policy, some may have to register at a hospital in another region and travel more than a hundred miles to see a doctor. It 'could have a huge ripple effect', she said. As concerned as they were about the new policies themselves, medical experts were equally worried about the way they came about. Sources at multiple VA hospitals, speaking on condition of anonymity because of fear of retaliation, told the Guardian that the rule changes were imposed without consultation with the system's doctors – a characterization the VA's Kasperowicz did not dispute. Such a move would run counter to standards established by the Joint Commission, a non-profit organization that accredits hospitals. Kasperowicz said the agency worked with the Joint Commission 'to ensure these changes would have no impact on VA's accreditation'. At its annual convention in Chicago this week, the American Medical Association's 733-member policymaking body passed a resolution reaffirming 'its commitment to medical staff self-governance … and urges all healthcare institutions, including the US Department of Veterans Affairs, to ensure that any amendments to medical staff bylaws are subject to approval by medical staff in accordance with Joint Commission standards'. The changes are part of a larger attack on the independence of medicine and science by the Trump administration, Caplan said, which has included restrictions and cuts at the National Institutes of Health and the Centers for Disease Control and Prevention, where the secretary of the Department of Health and Human Services, Robert F Kennedy Jr, last week fired every member of a key panel that advises the government on vaccines. The Guardian has earlier reported on a VA edict forbidding agency researchers from publishing in scientific journals without clearance from the agency's political appointees.
